Over $1.3 million of neurological research funding
Over $1.3 million of neurological research funding in July round
The Neurological Foundation is pleased to announce that over $1.3 million of research funding has been allocated in its July grant round.
The July grants allocated include the funding of the following projects which will be carried out at the University of Auckland, the University of Otago Christchurch and the University of Otago:
- Epilepsy: A proof-of-principle
study of a tailor-made, intranasal anti-convulsant drug
- Fragile X Syndrome: Developing an authentic research model of Fragile X Syndrome using an innovative New Zealand-developed technology
- Multiple sclerosis: Can a new drug-delivery system specifically target lesions in a model of multiple sclerosis to improve brain function?
- Parkinson’s disease: Investigating the role of sub-thalamic nucleus activity in impulsivity in a model using optogenetic technology
- Alzheimer’s disease: The investigation of a neuroprotective protein’s potential to rescue memory function
- Epilepsy: A laboratory based study to determine reliable methods for examining the effect of cannabidiol in epilepsy
- Brain function: Investigating the mechanisms of proteins in oxidative stress in brain disorders
- Stroke: Investigating a new approach to brain stimulation in a model of stroke to optimise recovery
- Traumatic brain injury: Development of a skin/skull/brain model to measure impact forces to the head and brain-injury mechanisms
- Schizophrenia and ADHD-like hyperactivity: Measuring changes in brain circuitry to increase knowledge of the anatomical basis of schizophrenia and ADHD-like hyperactivity
All lead investigator details are included in the attached, along with summaries of each grant.